Meryx Company
Meryx is a biotechnology company that develops orally bio-available cancer drugs targeting receptor tyrosine kinases.
Technology:
Others
Industry:
PharmTech
Headquarters:
Chapel Hill, North Carolina, United States
Founded Date:
2013
Estimated Revenue:
Less than $1M
Register and Claim Ownership